104 related articles for article (PubMed ID: 38747814)
1. Identifying malignant mesothelioma by a pathological survey using the São Paulo state hospital cancer registry, Brazil.
Bernardi FDC; Algranti E; Dolhnikoff M; Pinto CAL; Oliveira IM; Coletta ENAM; Silva ECAD; Nunes AJF; Veneziano DB; Luizaga CTM; Lorenzi RL; Silva DRME; Mauad T
J Bras Pneumol; 2024; 50(2):e20230343. PubMed ID: 38747814
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F
Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912
[TBL] [Abstract][Full Text] [Related]
3. Improving the Accuracy of Mesothelioma Diagnosis in China.
Guo Z; Carbone M; Zhang X; Su D; Sun W; Lou J; Gao Z; Shao D; Chen J; Zhang G; Hu J; Chen K; Wang F; Pass HI; Yu H; Napolitano A; Yang H; Mao W
J Thorac Oncol; 2017 Apr; 12(4):714-723. PubMed ID: 28007630
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
[TBL] [Abstract][Full Text] [Related]
5. The role of immunohistochemical evaluation in the diagnosis of malignant mesothelioma of the pleura.
Panjković M; Lovrenski A; Eri Z; Usaj SK; Tegeltija D; Krcedinac J
Vojnosanit Pregl; 2013 Nov; 70(11):1010-4. PubMed ID: 24397195
[TBL] [Abstract][Full Text] [Related]
6. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
[TBL] [Abstract][Full Text] [Related]
7. The role of endobronchial ultrasound-guided fine needle aspiration in the diagnosis of pleural mesothelioma.
Ghigna MR; Crutu A; Florea V; Soummer-Feulliet S; Baldeyrou P
Cytopathology; 2016 Aug; 27(4):284-8. PubMed ID: 26315262
[TBL] [Abstract][Full Text] [Related]
8. Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.
Ascoli V; Minelli G; Cozzi I; Romeo E; Carnovale Scalzo C; Ancona L; Forastiere F
Pathol Res Pract; 2016 Oct; 212(10):886-892. PubMed ID: 27485167
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis.
Parra-Medina R; Castañeda-González JP; Chaves-Cabezas V; Alzate JP; Chaves JJ
Pathol Res Pract; 2024 May; 257():155276. PubMed ID: 38603842
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
Mansour MSI; Huseinzade A; Seidal T; Hejny K; Maty A; Taheri-Eilagh F; Mager U; Dejmek A; Dobra K; Brunnström H
Cytopathology; 2023 Sep; 34(5):456-465. PubMed ID: 37337638
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report.
Pezzuto F; Vimercati L; Fortarezza F; Marzullo A; Pennella A; Cavone D; Punzi A; Caporusso C; d'Amati A; Lettini T; Serio G
Diagn Pathol; 2021 Jul; 16(1):64. PubMed ID: 34294087
[TBL] [Abstract][Full Text] [Related]
12. Risk of second primary cancers after malignant mesothelioma and vice versa.
Chen T; Kharazmi E; Lou J; Zhang X; Sundquist K; Hemminki K
Cancer Lett; 2016 Aug; 379(1):94-9. PubMed ID: 27260871
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry.
Sandeck HP; Røe OD; Kjærheim K; Willén H; Larsson E
Diagn Pathol; 2010 Jul; 5():47. PubMed ID: 20602796
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in malignant pleural mesothelioma.
Davidson B
Hum Pathol; 2015 Jun; 46(6):789-804. PubMed ID: 25824607
[TBL] [Abstract][Full Text] [Related]
15. On the diagnosis of malignant pleural mesothelioma: a necropsy-based study of 171 cases (1997-2016).
Barbieri PG
Tumori; 2019 Aug; 105(4):361-362. PubMed ID: 30592233
[No Abstract] [Full Text] [Related]
16. High frequency and severity of pleural changes in former workers exposed to anthophyllite associated with other contaminating amphibole asbestos in Brazil.
Macedo RF; Cerqueira EMFP; Algranti E; Silva D; De Capitani EM
Am J Ind Med; 2019 Jun; 62(6):503-510. PubMed ID: 31046142
[TBL] [Abstract][Full Text] [Related]
17. [A proposal for the creation of a system to monitor cases of malignant mesothelioma in Curitiba, Paraná, Brazil].
Kalinke LP; Kalinke MA; Sarquis LMM; Marcondes L; Halfeld T; Mensi C; Consonni D
Cad Saude Publica; 2018 Sep; 34(9):e00171917. PubMed ID: 30281709
[TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma.
Muruganandan S; Alfonso H; Franklin P; Shilkin K; Segal A; Olsen N; Reid A; de Klerk N; Musk AB; Brims F
Br J Cancer; 2017 Mar; 116(6):703-708. PubMed ID: 28196068
[TBL] [Abstract][Full Text] [Related]
19. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
McGregor SM; Dunning R; Hyjek E; Vigneswaran W; Husain AN; Krausz T
Hum Pathol; 2015 Nov; 46(11):1670-8. PubMed ID: 26376834
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Cytokeratin 20 Reactivity in Epithelioid Malignant Mesothelioma: A Case Report.
Manur R; Lamzabi I
Appl Immunohistochem Mol Morphol; 2019; 27(10):e93-e96. PubMed ID: 28248731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
